{"id":"W2032490154","doi":"10.2174/157488406778249325","title":"Sorafenib (BAY 43-9006): Review of Clinical Development","year":2006,"lang":"en","type":"review","venue":"Current Clinical Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Sorafenib; Medicine; Hepatocellular carcinoma; Rash; Pharmacology; Tyrosine-kinase inhibitor; Renal cell carcinoma; Internal medicine; Platelet-derived growth factor receptor; Oncology; Toxicity; Cancer; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003662478,0.0007411413,0.004503471,0.00009919015,0.00006988593,0.00000784056,0.00106388,0.001200911,0.0004134215],"category_scores_gemma":[0.000820784,0.0006027712,0.002425428,0.0002145345,0.000460269,0.000003607704,0.000714787,0.001317259,0.0003405358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003019372,"about_ca_system_score_gemma":0.002340579,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":9.257986e-7,"about_ca_topic_score_gemma":0.000002911454,"domain_scores_codex":[0.9894855,0.002144062,0.006082753,0.001365621,0.0003069319,0.0006151574],"domain_scores_gemma":[0.9955636,0.0004795227,0.002506049,0.0007736727,0.0002790832,0.0003980407],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002655612,0.0007629285,0.00009908684,0.05020495,0.0003571866,0.00001113418,6.290866e-7,6.250466e-8,0.000005853587,0.00001357053,0.2361454,0.7123726],"study_design_scores_gemma":[0.0009649721,0.0003659879,0.00003946459,0.01570376,0.001556386,0.00001975233,3.266149e-7,6.394669e-7,0.00004610443,0.000005907071,0.9807155,0.000581218],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007632222,0.9836887,0.0001392792,0.0000384458,0.01304766,0.001486749,0.0001399959,0.00002760991,0.001355262],"genre_scores_gemma":[0.000006013833,0.9892977,0.0004138733,0.0007190637,0.005749315,0.0002543879,0.002749933,0.00008311779,0.0007266076],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7445701,"threshold_uncertainty_score":0.9996424,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2477982877687997,"score_gpt":0.5447069939674991,"score_spread":0.2969087061986994,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}